{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:10:16Z","timestamp":1794507016334,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013238","name":"Faculty of Medicine Siriraj Hospital, Mahidol University","doi-asserted-by":"publisher","award":["R016634001"],"award-info":[{"award-number":["R016634001"]}],"id":[{"id":"10.13039\/501100013238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013238","name":"Faculty of Medicine Siriraj Hospital, Mahidol University","doi-asserted-by":"publisher","award":["R016634001"],"award-info":[{"award-number":["R016634001"]}],"id":[{"id":"10.13039\/501100013238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013238","name":"Faculty of Medicine Siriraj Hospital, Mahidol University","doi-asserted-by":"publisher","award":["R016634001"],"award-info":[{"award-number":["R016634001"]}],"id":[{"id":"10.13039\/501100013238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98107-8","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T15:31:32Z","timestamp":1745249492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Characterization of neutralizing versus binding antibody and T cell responses to varicella-zoster virus in the elderly"],"prefix":"10.1038","volume":"15","author":[{"given":"Suthee","family":"Mangmee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supasek","family":"Kardkarnklai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suphanun","family":"Phuphanitcharoenkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarocha","family":"Suthisawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oranit","family":"Li-Khit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattaya","family":"Kamchompoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae Apaivongse","family":"Coad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patimaporn","family":"Wongprompitak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarupa","family":"Soongsathitanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tararaj","family":"Dharakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamol","family":"Suwannakarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chutikarn","family":"Chaimayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weerasak","family":"Muangpaisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somboon","family":"Intalapaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasert","family":"Assantachai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobporn","family":"Boonnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"98107_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1186\/s12879-020-05648-6","volume":"20","author":"C Mu\u00f1oz-Quiles","year":"2020","unstructured":"Mu\u00f1oz-Quiles, C., L\u00f3pez-Lacort, M., D\u00edez-Domingo, J. & Orrico-S\u00e1nchez, A. Herpes Zoster risk and burden of disease in immunocompromised populations: a population-based study using health system integrated databases, 2009\u20132014. BMC Infect. Dis. 20, 905. https:\/\/doi.org\/10.1186\/s12879-020-05648-6 (2020).","journal-title":"BMC Infect. Dis."},{"key":"98107_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.idc.2017.07.016","volume":"31","author":"AR John","year":"2017","unstructured":"John, A. R. & Canaday, D. H. Herpes Zoster in the older adult. Infect. Dis. Clin. North. Am. 31, 811\u2013826. https:\/\/doi.org\/10.1016\/j.idc.2017.07.016 (2017).","journal-title":"Infect. Dis. Clin. North. Am."},{"key":"98107_CR3","doi-asserted-by":"publisher","first-page":"ofaa005","DOI":"10.1093\/ofid\/ofaa005","volume":"7","author":"F Marra","year":"2020","unstructured":"Marra, F., Parhar, K., Huang, B. & Vadlamudi, N. Risk factors for herpes Zoster infection: a meta-analysis. Open. Forum Infect. Dis. 7, ofaa005. https:\/\/doi.org\/10.1093\/ofid\/ofaa005 (2020).","journal-title":"Open. Forum Infect. Dis."},{"key":"98107_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1086\/528696","volume":"197","author":"MJ Levin","year":"2008","unstructured":"Levin, M. J. et al. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes Zoster vaccine. J. Infect. Dis. 197, 825\u2013835. https:\/\/doi.org\/10.1086\/528696 (2008).","journal-title":"J. Infect. Dis."},{"key":"98107_CR5","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1086\/605611","volume":"200","author":"A Weinberg","year":"2009","unstructured":"Weinberg, A. et al. Varicella-zoster virus-specific immune responses to herpes Zoster in elderly participants in a trial of a clinically effective Zoster vaccine. J. Infect. Dis. 200, 1068\u20131077. https:\/\/doi.org\/10.1086\/605611 (2009).","journal-title":"J. Infect. Dis."},{"key":"98107_CR6","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/infdis\/jiu279","volume":"210","author":"PB Gilbert","year":"2014","unstructured":"Gilbert, P. B. et al. Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes Zoster vaccine, demonstrated via the vaccine efficacy curve. J. Infect. Dis. 210, 1573\u20131581. https:\/\/doi.org\/10.1093\/infdis\/jiu279 (2014).","journal-title":"J. Infect. Dis."},{"key":"98107_CR7","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1016\/j.vaccine.2019.09.031","volume":"37","author":"H Asada","year":"2019","unstructured":"Asada, H. VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence of herpes Zoster and the severity of skin symptoms and Zoster-associated pain: the SHEZ study. Vaccine 37, 6776\u20136781. https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.031 (2019).","journal-title":"Vaccine"},{"key":"98107_CR8","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/jid.2015.63","volume":"135","author":"M Vukmanovic-Stejic","year":"2015","unstructured":"Vukmanovic-Stejic, M. et al. The characterization of varicella Zoster virus-specific T cells in skin and blood during aging. J. Invest. Dermatol. 135, 1752\u20131762. https:\/\/doi.org\/10.1038\/jid.2015.63 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"98107_CR9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4049\/jimmunol.1700290","volume":"199","author":"A Weinberg","year":"2017","unstructured":"Weinberg, A. et al. Varicella-zoster virus-specific cellular immune responses to the live attenuated Zoster vaccine in young and older adults. J. Immunol. 199, 604\u2013612. https:\/\/doi.org\/10.4049\/jimmunol.1700290 (2017).","journal-title":"J. Immunol."},{"key":"98107_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00430-019-00605-w","volume":"208","author":"M Jergovi\u0107","year":"2019","unstructured":"Jergovi\u0107, M., Contreras, N. A. & Nikolich-\u017dugich, J. Impact of CMV upon immune aging: facts and fiction. Med. Microbiol. Immunol. 208, 263\u2013269. https:\/\/doi.org\/10.1007\/s00430-019-00605-w (2019).","journal-title":"Med. Microbiol. Immunol."},{"key":"98107_CR11","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1080\/21645515.2015.1037999","volume":"11","author":"B Ogunjimi","year":"2015","unstructured":"Ogunjimi, B. et al. Cytomegalovirus seropositivity is associated with herpes Zoster. Hum. Vaccin Immunother. 11, 1394\u20131399. https:\/\/doi.org\/10.1080\/21645515.2015.1037999 (2015).","journal-title":"Hum. Vaccin Immunother"},{"key":"98107_CR12","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/jmv.23749","volume":"86","author":"B Ogunjimi","year":"2014","unstructured":"Ogunjimi, B., Theeten, H., Hens, N. & Beutels, P. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation. J. Med. Virol. 86, 812\u2013819. https:\/\/doi.org\/10.1002\/jmv.23749 (2014).","journal-title":"J. Med. Virol."},{"key":"98107_CR13","unstructured":"Bureau of Epidemiology. Department of Disease Control. Ministry of Public Health. Thailand. Annual epidemiological surveillance report 2011, (2006). https:\/\/apps-doe.moph.go.th\/boeeng\/annual\/Annual\/AESR2011\/index.html"},{"key":"98107_CR14","unstructured":"Infectious Diseases Association of Thailand. Recommended adult and elderly immunization schedule 2023, (2023). https:\/\/idthai.org\/Contents\/Views\/?d=!8!11!!1005!"},{"key":"98107_CR15","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried, L. P. et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. Biol. Sci. Med. Sci. 56, M146\u2013M157. https:\/\/doi.org\/10.1093\/gerona\/56.3.M146 (2001).","journal-title":"J. Gerontol. Biol. Sci. Med. Sci."},{"key":"98107_CR16","doi-asserted-by":"publisher","first-page":"eabo2847","DOI":"10.1126\/scitranslmed.abo2847","volume":"15","author":"JM Carre\u00f1o","year":"2023","unstructured":"Carre\u00f1o, J. M. et al. An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Sci. Transl Med. 15, eabo2847. https:\/\/doi.org\/10.1126\/scitranslmed.abo2847 (2023).","journal-title":"Sci. Transl Med."},{"key":"98107_CR17","doi-asserted-by":"publisher","unstructured":"Karron, R. A. et al. Binding and neutralizing antibody responses to SARS-CoV-2 in very young children exceed those in adults. JCI Insight. 7 https:\/\/doi.org\/10.1172\/jci.insight.157963 (2022).","DOI":"10.1172\/jci.insight.157963"},{"key":"98107_CR18","doi-asserted-by":"publisher","unstructured":"Amanat, F. et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell 184, 3936\u20133948.e3910, (2021). https:\/\/doi.org\/10.1016\/j.cell.2021.06.005","DOI":"10.1016\/j.cell.2021.06.005"},{"key":"98107_CR19","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1017\/S0950268818001619","volume":"146","author":"S Medi\u0107","year":"2018","unstructured":"Medi\u0107, S. et al. Seroepidemiology of varicella Zoster virus infection in Vojvodina, Serbia. Epidemiol. Infect. 146, 1593\u20131601. https:\/\/doi.org\/10.1017\/S0950268818001619 (2018).","journal-title":"Epidemiol. Infect."},{"key":"98107_CR20","doi-asserted-by":"publisher","unstructured":"Tsou, M. T. & Shao, H. H. Varicella Seroprevalence in healthcare workers at a medical center following changes in National and local hospital vaccination policies. Int. J. Environ. Res. Public. Health. 16 https:\/\/doi.org\/10.3390\/ijerph16193544 (2019).","DOI":"10.3390\/ijerph16193544"},{"key":"98107_CR21","doi-asserted-by":"publisher","first-page":"2367283","DOI":"10.1080\/21645515.2024.2367283","volume":"20","author":"T Thongmee","year":"2024","unstructured":"Thongmee, T. et al. Seroprevalence of antibodies against varicella Zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand. Hum. Vaccin Immunother. 20, 2367283. https:\/\/doi.org\/10.1080\/21645515.2024.2367283 (2024).","journal-title":"Hum. Vaccin Immunother"},{"key":"98107_CR22","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/infdis\/jiw462","volume":"214","author":"A Lelic","year":"2016","unstructured":"Lelic, A. et al. Immunogenicity of varicella vaccine and Immunologic predictors of response in a cohort of elderly nursing home residents. J. Infect. Dis. 214, 1905\u20131910. https:\/\/doi.org\/10.1093\/infdis\/jiw462 (2016).","journal-title":"J. Infect. Dis."},{"key":"98107_CR23","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1086\/379048","volume":"188","author":"MJ Levin","year":"2003","unstructured":"Levin, M. J. et al. Decline in varicella-zoster virus (VZV)\u2013specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J. Infect. Dis. 188, 1336\u20131344. https:\/\/doi.org\/10.1086\/379048 (2003).","journal-title":"J. Infect. Dis."},{"key":"98107_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jcv.2012.06.008","volume":"55","author":"H Tang","year":"2012","unstructured":"Tang, H. et al. A community-based survey of varicella-zoster virus-specific immune responses in the elderly. J. Clin. Virol. 55, 46\u201350. https:\/\/doi.org\/10.1016\/j.jcv.2012.06.008 (2012).","journal-title":"J. Clin. Virol."},{"key":"98107_CR25","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1080\/21645515.2020.1847582","volume":"17","author":"D van Oorschot","year":"2021","unstructured":"van Oorschot, D. et al. A systematic literature review of herpes Zoster incidence worldwide. Hum. Vaccin Immunother. 17, 1714\u20131732. https:\/\/doi.org\/10.1080\/21645515.2020.1847582 (2021).","journal-title":"Hum. Vaccin Immunother"},{"key":"98107_CR26","unstructured":"Nussbaum, R. Theories on varicella zoster virus reactivation based on shingles patterns, (2014). https:\/\/touroscholar.touro.edu\/sjlcas\/vol8\/iss1\/10\/"},{"key":"98107_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3389\/fimmu.2015.00553","volume":"6","author":"JJ Sei","year":"2015","unstructured":"Sei, J. J. et al. Effector and central memory poly-functional CD4+ and CD8+ T cells are boosted upon ZOSTAVAX\u00ae vaccination. Front. Immunol. 6, 553. https:\/\/doi.org\/10.3389\/fimmu.2015.00553 (2015).","journal-title":"Front. Immunol."},{"key":"98107_CR28","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1038\/s41467-021-24377-1","volume":"12","author":"JH Jung","year":"2021","unstructured":"Jung, J. H. et al. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells. Nat. Commun. 12, 4043. https:\/\/doi.org\/10.1038\/s41467-021-24377-1 (2021).","journal-title":"Nat. Commun."},{"key":"98107_CR29","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/jmv.23427","volume":"84","author":"NM van Besouw","year":"2012","unstructured":"van Besouw, N. M. et al. Systemic varicella Zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients. J. Med. Virol. 84, 2018\u20132025. https:\/\/doi.org\/10.1002\/jmv.23427 (2012).","journal-title":"J. Med. Virol."},{"key":"98107_CR30","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s43587-022-00292-y","volume":"2","author":"M Palacios-Pedrero","year":"2022","unstructured":"Palacios-Pedrero, M. et al. Signs of Immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults. Nat. Aging. 2, 896\u2013905. https:\/\/doi.org\/10.1038\/s43587-022-00292-y (2022).","journal-title":"Nat. Aging"},{"key":"98107_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1128\/jvi.52.1.293-297.1984","volume":"52","author":"PM Keller","year":"1984","unstructured":"Keller, P. M., Neff, B. J. & Ellis, R. W. Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J. Virol. 52, 293\u2013297. https:\/\/doi.org\/10.1128\/jvi.52.1.293-297.1984 (1984).","journal-title":"J. Virol."},{"key":"98107_CR32","doi-asserted-by":"publisher","unstructured":"Sullivan, N. L. et al. Breadth and functionality of varicella-zoster virus glycoprotein-specific antibodies identified after Zostavax vaccination in humans. J. Virol. 92 https:\/\/doi.org\/10.1128\/jvi.00269-18 (2018).","DOI":"10.1128\/jvi.00269-18"},{"key":"98107_CR33","doi-asserted-by":"publisher","first-page":"8172","DOI":"10.1128\/jvi.00435-11","volume":"85","author":"K Shiraki","year":"2011","unstructured":"Shiraki, K. et al. Neutralizing anti-gH antibody of varicella-zoster virus modulates distribution of gH and induces gene regulation, mimicking latency. J. Virol. 85, 8172\u20138180. https:\/\/doi.org\/10.1128\/jvi.00435-11 (2011).","journal-title":"J. Virol."},{"key":"98107_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1128\/jvi.02561-12","volume":"87","author":"M Birlea","year":"2013","unstructured":"Birlea, M. et al. Human anti-varicella-zoster virus (VZV) Recombinant monoclonal antibody produced after Zostavax immunization recognizes the gH\/gL complex and neutralizes VZV infection. J. Virol. 87, 415\u2013421. https:\/\/doi.org\/10.1128\/jvi.02561-12 (2013).","journal-title":"J. Virol."},{"key":"98107_CR35","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/gerona\/gly287","volume":"74","author":"JY Choi","year":"2018","unstructured":"Choi, J. Y. et al. Immunogenicity of the varicella-zoster vaccine in community-dwelling non-robust elderly individuals compared to robust elderly individuals: a prospective cohort study. J. Gerontol. Biol. Sci. Med. Sci. 74, 1225\u20131230. https:\/\/doi.org\/10.1093\/gerona\/gly287 (2018).","journal-title":"J. Gerontol. Biol. Sci. Med. Sci."},{"key":"98107_CR36","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/jgs.16917","volume":"69","author":"D Curran","year":"2021","unstructured":"Curran, D. et al. Recombinant Zoster vaccine is efficacious and safe in frail individuals. J. Am. Geriatr. Soc. 69, 744\u2013752. https:\/\/doi.org\/10.1111\/jgs.16917 (2021).","journal-title":"J. Am. Geriatr. Soc."},{"key":"98107_CR37","doi-asserted-by":"publisher","first-page":"8218","DOI":"10.4049\/jimmunol.175.12.8218","volume":"175","author":"JM Fletcher","year":"2005","unstructured":"Fletcher, J. M. et al. Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J. Immunol. 175, 8218\u20138225. https:\/\/doi.org\/10.4049\/jimmunol.175.12.8218 (2005).","journal-title":"J. Immunol."},{"key":"98107_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41541-022-00545-2","volume":"7","author":"SY Park","year":"2022","unstructured":"Park, S. Y. et al. Development of antibody-dependent cellular cytotoxicity in response to Recombinant and live-attenuated herpes Zoster vaccines. NPJ Vaccines. 7, 123. https:\/\/doi.org\/10.1038\/s41541-022-00545-2 (2022).","journal-title":"NPJ Vaccines"},{"key":"98107_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.20411\/pai.v7i2.560","volume":"7","author":"W Jin","year":"2022","unstructured":"Jin, W. et al. Differential CD4+ T-cell cytokine and cytotoxic responses between reactivation and latent phases of herpes Zoster infection. Pathog Immun. 7, 171\u2013188. https:\/\/doi.org\/10.20411\/pai.v7i2.560 (2022).","journal-title":"Pathog Immun."},{"key":"98107_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1128\/aac.18.3.443","volume":"18","author":"KK Biron","year":"1980","unstructured":"Biron, K. K. & Elion, G. B. In vitro susceptibility of varicella-zoster virus to acyclovir. Antimicrob. Agents Chemother. 18, 443\u2013447. https:\/\/doi.org\/10.1128\/aac.18.3.443 (1980).","journal-title":"Antimicrob. Agents Chemother."},{"key":"98107_CR41","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jviromet.2014.05.027","volume":"206","author":"A Sloutskin","year":"2014","unstructured":"Sloutskin, A. & Goldstein, R. S. Laboratory Preparation of varicella-zoster virus: concentration of virus-containing Supernatant, use of a debris fraction and Magnetofection for consistent cell-free VZV infections. J. Virol. Methods. 206, 128\u2013132. https:\/\/doi.org\/10.1016\/j.jviromet.2014.05.027 (2014).","journal-title":"J. Virol. Methods"},{"key":"98107_CR42","doi-asserted-by":"publisher","unstructured":"Schmid, D. S. et al. Comparative antibody responses to the live-attenuated and Recombinant herpes Zoster vaccines. J. Virol. 95 https:\/\/doi.org\/10.1128\/jvi.00240-21 (2021).","DOI":"10.1128\/jvi.00240-21"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98107-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98107-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98107-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T15:31:35Z","timestamp":1745249495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98107-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98107"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98107-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13776"}}